These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 39179542)

  • 1. The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders.
    Kantor B; O'Donovan B; Rittiner J; Hodgson D; Lindner N; Guerrero S; Dong W; Zhang A; Chiba-Falek O
    Nat Commun; 2024 Aug; 15(1):7259. PubMed ID: 39179542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-in-one AAV-delivered epigenome-editing platform:
    Kantor B; Odonovan B; Rittiner J; Hodgson D; Lindner N; Guerrero S; Dong W; Zhang A; Chiba-Falek O
    bioRxiv; 2024 May; ():. PubMed ID: 38798630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR Systems Suitable for Single AAV Vector Delivery.
    Stevanovic M; Piotter E; McClements ME; MacLaren RE
    Curr Gene Ther; 2022; 22(1):1-14. PubMed ID: 34620062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
    Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
    Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
    Lau CH; Suh Y
    Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing.
    Moses C; Hodgetts SI; Nugent F; Ben-Ary G; Park KK; Blancafort P; Harvey AR
    Sci Rep; 2020 Jul; 10(1):11393. PubMed ID: 32647121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA.
    Woodward EA; Wang E; Wallis C; Sharma R; Tie AWJ; Murthy N; Blancafort P
    Methods Mol Biol; 2024; 2842():267-287. PubMed ID: 39012601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
    Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
    J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR-Cas12f1 System Delivered with All-in-One Adeno-Associated Virus.
    Cui T; Cai B; Tian Y; Liu X; Liang C; Gao Q; Li B; Ding Y; Li R; Zhou Q; Li W; Teng F
    Adv Sci (Weinh); 2024 May; 11(19):e2308095. PubMed ID: 38408137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
    Goubert D; Koncz M; Kiss A; Rots MG
    Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Delivery of Compact CRISPR-Cas12f for Gene Editing Applications.
    Sharrar A; Meacham Z; Staples-Ager J; Arake de Tacca L; Rabuka D; Collingwood T; Schelle M
    CRISPR J; 2024 Jun; 7(3):150-155. PubMed ID: 38695159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of versatile cloning platforms for transgene expression and dCas9-based epigenome editing.
    Haldeman JM; Conway AE; Arlotto ME; Slentz DH; Muoio DM; Becker TC; Newgard CB
    Nucleic Acids Res; 2019 Feb; 47(4):e23. PubMed ID: 30590691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
    Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
    BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice for in vivo epigenome editing with CRISPR-based systems.
    Gemberling MP; Siklenka K; Rodriguez E; Tonn-Eisinger KR; Barrera A; Liu F; Kantor A; Li L; Cigliola V; Hazlett MF; Williams CA; Bartelt LC; Madigan VJ; Bodle JC; Daniels H; Rouse DC; Hilton IB; Asokan A; Ciofani M; Poss KD; Reddy TE; West AE; Gersbach CA
    Nat Methods; 2021 Aug; 18(8):965-974. PubMed ID: 34341582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of a multiplex CRISPR/Cas system for use as an antiviral therapeutic.
    Kennedy EM; Kornepati AVR; Mefferd AL; Marshall JB; Tsai K; Bogerd HP; Cullen BR
    Methods; 2015 Dec; 91():82-86. PubMed ID: 26291065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency.
    Fry LE; Peddle CF; Stevanovic M; Barnard AR; McClements ME; MacLaren RE
    CRISPR J; 2020 Aug; 3(4):276-283. PubMed ID: 32833533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of a compact, high-fidelity EbCas12a variant that can be packaged with its crRNA into an all-in-one AAV vector delivery system.
    Wang H; Zhou J; Lei J; Mo G; Wu Y; Liu H; Pang Z; Du M; Zhou Z; Paek C; Sun Z; Chen Y; Wang Y; Chen P; Yin L
    PLoS Biol; 2024 May; 22(5):e3002619. PubMed ID: 38814985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
    Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
    Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenome Editing in the Brain.
    Bashtrykov P; Jeltsch A
    Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia.
    Pan X; Philippen L; Lahiri SK; Lee C; Park SH; Word TA; Li N; Jarrett KE; Gupta R; Reynolds JO; Lin J; Bao G; Lagor WR; Wehrens XHT
    Circ Res; 2018 Sep; 123(8):953-963. PubMed ID: 30355031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.